Monte Rosa Therapeutics (GLUE) Payables (2020 - 2026)
Monte Rosa Therapeutics (GLUE) reported Payables of $25.77 million for Q2 2026, up 87.2% from $13.77 million a year earlier and up 0.7% from the prior quarter.
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Monte Rosa Therapeutics posted Payables of $26.69 million, up 42.1% from FY2024.
- Payables has increased for five consecutive years, with a five-year compound annual growth rate of 30.5% (FY2020 to FY2025).
- By year, Payables came in at $18.79 million in FY2024 (+28.7%), $14.6 million in FY2023 (+0.1%), $14.58 million in FY2022 (+44.6%) and $10.08 million in FY2021 (+42.7%).
- Five-year quarterly Payables spans a low of $6.46 million in Q1 2022 and a high of $26.69 million in Q4 2025.
- Year over year, Payables has now increased in each of the last 17 quarters, with growth averaging 37.5% over the last eight quarters.
- Across the past five years, year-over-year growth in Payables ran from 0.1% in Q4 2023 to 87.2% in Q2 2026.
- Per Business Quant data, the three quarters before Q2 2026 came in at $25.59 million (Q1 2026), $26.69 million (Q4 2025) and $17.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Monte Rosa Therapeutics | 998.00 Mn | 409.81 Mn | - | 25.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.77 Mn |
| Mar 31, 2026 | 25.59 Mn |
| Dec 31, 2025 | 26.69 Mn |
| Sep 30, 2025 | 17.90 Mn |
| Jun 30, 2025 | 13.77 Mn |
| Mar 31, 2025 | 16.29 Mn |
| Dec 31, 2024 | 18.79 Mn |
| Sep 30, 2024 | 15.10 Mn |
| Jun 30, 2024 | 12.76 Mn |
| Mar 31, 2024 | 10.71 Mn |
| Dec 31, 2023 | 14.60 Mn |
| Sep 30, 2023 | 14.23 Mn |
| Jun 30, 2023 | 11.11 Mn |
| Mar 31, 2023 | 10.24 Mn |
| Dec 31, 2022 | 14.58 Mn |
| Sep 30, 2022 | 9.75 Mn |
| Jun 30, 2022 | 7.82 Mn |
| Mar 31, 2022 | 6.46 Mn |
| Dec 31, 2021 | 10.08 Mn |
| Sep 30, 2021 | 9.21 Mn |
API Access
Monte Rosa Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=GLUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();